Breaking the cycle of institutional betrayal and the culture of silence requires decisive actions to promote transparency, accountability and supportive environments in both academia and industry.

Please enable JavaScript to proceed.

Nature Biotechnology is a monthly journal publishing new concepts in biological technology of relevance to bioengineering, medicine, energy, agriculture, food ...

Optimized long-read sequencing constructs megabase-scale genome assemblies from complex soil samples.

A screen for protein degraders discovers hits by imaging cell survival.

As the extinction of plants and animals accelerates, our dependence on the natural world is deepening

For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and ...

"In IRL events, there's a hell of a lot more accountability, and people behave very differently in person than they do virtually," founder Lucy Rout said.

Recent moves of note in and around the biotech and pharma industries.

Dear Employer Partners, The NYU Center for Data Science (CDS) Fall 2025 Career Fair will take place on Thursday, September 25, 2025 from 1:30PM-4:30PM ET in our open space at 60 Fifth Avenue and is ...

Nature Biotechnology - Ocean-grown bioplastics

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Seaport Therapeutics is modifying central nervous system drugs for delivery throug...

UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences.

For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and ...

A λ exonuclease system exhibits protospacer-adjacent motif-independent DNA-binding specificity, enabling diagnostic and imaging applications.

The U.S. dollar faces a variety of headwinds heading into the second half of the year that could have important investing implications.

CNBC's Jim Cramer on Monday marveled at the stock performance of IBM under CEO Arvind Krishna.

Costs for scientific progress and the public could be profound if the Trump administration succeeds in significantly cutting research funding.

Thinking With Machines: The Brave New World of AI [Dhar, Vasant] on Amazon.com. *FREE* shipping on qualifying offers. Thinking With Machines: The Brave New World of AI

Visual Self-Supervised Learning (SSL) currently underperforms Contrastive Language-Image Pretraining (CLIP) in multimodal settings such as Visual Question Answering (VQA). This multimodal gap is often...

Nature Biotechnology - Openness guides discovery

The first cancer vaccines matched to a person’s unique tumor neoantigens are forging ahead, with expectations running high as the field awaits results from the first pivotal trial.

The tool, described in Nature Biotechnology, will help understand how changes in our DNA affect proteins and ultimately contribute to cancer, neurodegenerative diseases, and other conditions.

Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity f...

A new era of "free intelligence" powered by AI will change the way humans work, says billionaire Microsoft co-founder Bill Gates.